# Probiotics for the Prevention of Immunotherapy Induced Colitis in Patients Receiving Immunotherapy

> **NCT06508034** · NA · SUSPENDED · sponsor: **Mayo Clinic** · enrollment: 12 (estimated)

## Conditions studied

- Malignant Solid Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **DIETARY_SUPPLEMENT:** Live Freeze-Dried Lactic Acid Bacteria Probiotic
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT06508034
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2024-07-31
- **Primary completion:** 2027-08-30
- **Final completion:** 2027-08-30
- **Target enrollment:** 12 (ESTIMATED)
- **Why stopped:** Change in funding status
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06508034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06508034, "Probiotics for the Prevention of Immunotherapy Induced Colitis in Patients Receiving Immunotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06508034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*